Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers

Summary

This Phase 1, randomized, placebo-controlled, double-blind, healthy volunteer study tested the safety, tolerability, and plasma pharmacokinetics of two different concentrations of TAT4 Gel administered once daily to 50 cm2 of skin for 14 days.

Timeline

Start

2014-10

Primary completion

2014-12

Completion

2014-12

Drugs

Indications